Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia
- PMID: 4092001
- PMCID: PMC1400822
- DOI: 10.1111/j.1365-2125.1985.tb05134.x
Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia
Abstract
Antipyrine salivary clearance and half-life and the rate of formation of three principal metabolites of antipyrine (4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine) were assessed in nine children with congenital adrenal hyperplasia, six of whom were salt-losers and three of whom were non-salt-losers. No differences were found in comparison with data obtained in normal children.
Similar articles
-
Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.Clin Pharmacol Ther. 1996 Jun;59(6):613-23. doi: 10.1016/S0009-9236(96)90001-6. Clin Pharmacol Ther. 1996. PMID: 8681486
-
Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.Xenobiotica. 1979 Nov;9(11):695-702. doi: 10.3109/00498257909042337. Xenobiotica. 1979. PMID: 119355
-
Antipyrine clearance in congenital adrenal hyperplasia.Clin Endocrinol (Oxf). 1986 Sep;25(3):233-9. doi: 10.1111/j.1365-2265.1986.tb01687.x. Clin Endocrinol (Oxf). 1986. PMID: 3791665
-
Prediction of xenobiotic metabolism by non-invasive methods.Pharmacol Toxicol. 1990 Aug;67(2):101-8. doi: 10.1111/j.1600-0773.1990.tb00793.x. Pharmacol Toxicol. 1990. PMID: 2123982 Review. No abstract available.
-
Dynamic interactions among host factors that influence antipyrine metabolism: implications for the design and interpretation of studies on ethnic pharmacokinetic variations.Prog Clin Biol Res. 1986;214:425-51. Prog Clin Biol Res. 1986. PMID: 3523515 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical